
TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Aesthetic professionals from around the world will be in Paris from June 3 to 5 for the 23nd edition of the IMCAS World Congress. With hundreds of professional development sessions being delivered by a world-renowned faculty, this is a one-of-a-kind educational experience that you will not want to miss.
The Congress also provides a unique opportunity to network with industry professionals through its wide array of social events and exhibitions.
The Venus Concept team would like to invite you to a series of workshops hosted by industry leaders on topics that stretch from the lastest trends in hair restoration to advances in non-invasive treatments.
Location:
Join us at the Hall Maillot A, booth #N240A and join one of the four sessions featuring our esteemed speakers.
Date and time: Friday, June 3, 2022 at 7:30am
Venue: Hyatt Regency Paris Etoile, 3 Place du Général Kœnig, 75017 Paris (located right next to the conference venue)
Location: Lab 1 + 2
Speakers:
Date and time: Friday, June 3, 2022 at 8:30am
Location: Room 143 - Level 1
Speakers:
Date and time: Saturday, June 4, 2022 at 10:30am
Location: Room 252 AB - Level 2
Speakers:
Date and time: Sunday June 5, 2022 at 9:08am
Location: Room 242AB - Level 2
Speakers:
We look forward to seeing you there for this exciting event! To register for one of the 4 speaker sessions, click the button below.
For more information call: (888) 907-0115 // info@venusconcept.com // 235 Yorkland Blvd., Suite 900, Toronto, ON, M2J 4Y8 Canada
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is licensed by Health Canada for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is licensed by Health Canada for temporary increase of skin tightening, temporary circumferential reduction, and temporary cellulite reduction.
Venus Versa™ is licensed by Health Canada as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are licensed by Health Canada for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are licensed by Health Canada for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is licensed by Health Canada for the treatment of acne vulgaris. The DiamondPolar™ applicator is licensed by Health Canada for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is licensed by Health Canada for dermatological procedures requiring ablation and resurfacing of the skin.
NeoGraft® is licensed by Health Canada with indication for use in suction-assisted follicular extraction and re-implantation. It is an auto-graft system and can be used on both male and female patients.
ARTAS iX™ is licensed by Health Canada with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
Venus Legacy™ is licensed by Health Canada for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Velocity™ is licensed by Health Canada for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
The Venus Viva™ is licensed by Health Canada as a non-invasive medical aesthetic device, intended for use in dermatologic and general surgical procedures requiring ablation and resurfacing of the skin, using the Viva™/Viva™ MD applicator, and reduction in the appearance of wrinkle and rhytides in Fitzpatrick skin types I - IV using the DiamondPolar™ applicator.
Venus Epileve™ is licensed by Health Canada for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Venus Freeze Plus™ is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of cellulite on the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators.
Venus Heal™ is licensed by Health Canada and can be used for the treatment of both acute and chronic disorders of the musculoskeletal system, such as muscle spasms, back pain, and soft tissue injuries, and results in effects such as pain relief, myorelaxation, increase of local blood circulation, and edema reduction.
Venus Glow™ provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Skin™ is a skin care line of various lotions and creams intended to improve different aspects of skin appearance, skin serums, and skin nourishment solutions.
Copyright © 2020 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More